An international Delphi consensus statement on metabolic dysfunction-associated fatty liver disease and risk of chronic kidney disease

doi:10.21037/hbsn-22-421

科研成果详情

题名	An international Delphi consensus statement on metabolic dysfunction-associated fatty liver disease and risk of chronic kidney disease
作者	Sun, Dan-Qin 1,2; Targher, Giovanni 3; Byrne, Christopher D.4,5,6; Wheeler, David C.7; Wong, Vincent Wai-Sun 8; Fan, Jian-Gao 9; Tilg, Herbert 10; Yuan, Wei-Jie 11; Wanner, Christoph 12; Gao, Xin 13; Long, Michelle T.14; Kanbay, Mehmet 15; Nguyen, Mindie H.16,17; Navaneethan, Sankar D.18,19,20; Yilmaz, Yusuf 21,22; Huang, Yuli 23; Gani, Rino A.24; Marzuillo, Pierluigi 25; Boursier, Jerome 26,27; Zhang, Huijie 28; Jung, Chan-Young 29; Chai, Jin 30; Valenti, Luca 31; Papatheodoridis, George 32; Musso, Giovanni 33,34; Wong, Yu-Jun 35,36; El-Kassas, Mohamed 37; Mendez-Sanchez, Nahum 38; Sookoian, Silvia 39; Pavlides, Michael 40; Duseja, Ajay 41; Holleboom, Adriaan G.42; Shi, Junping 43; Chan, Wah-Kheong 44; Fouad, Yasser 45; Yang, Junwei 46; Treeprasertsuk, Sombat 47; Cortez-Pinto, Helena 48; Hamaguchi, Masahide 49; Romero-Gomez, Manuel 50; Al Mahtab, Mamun 51; Ocama, Ponsiano 52; Nakajima, Atsushi 53; Dai, Chunsun 46; Eslam, Mohammed 54,55; Wei, Lai 56; George, Jacob 54,55; Zheng, Ming-Hua57,58
发表日期	2023-06-01
发表期刊	HEPATOBILIARY SURGERY AND NUTRITION 影响因子和分区
语种	英语
原始文献类型	Article ; Early Access
关键词	Metabolic dysfunction-associated fatty liver disease (MAFLD) non-alcoholic fatty liver disease (NAFLD) chronic kidney disease (CKD) consensus
其他关键词	LIFE-STYLE MODIFICATION ; CARDIOVASCULAR-DISEASE ; DIABETES-MELLITUS ; WEIGHT-LOSS ; NAFLD ; MAFLD ; FIBROSIS ; MORTALITY ; EXERCISE ; REDEFINITION
摘要	Background: With the rising global prevalence of fatty liver disease related to metabolic dysfunction, the association of this common liver condition with chronic kidney disease (CKD) has become increasingly evident. In 2020, the more inclusive term metabolic dysfunction-associated fatty liver disease (MAFLD) was proposed to replace the term non-alcoholic fatty liver disease (NAFLD). The observed association between MAFLD and CKD and our understanding that CKD can be a consequence of underlying metabolic dysfunction support the notion that individuals with MAFLD are at higher risk of having and developing CKD compared with those without MAFLD. However, to date, there is no appropriate guidance on CKD in individuals with MAFLD. Furthermore, there has been little attention paid to the link between MAFLD and CKD in the Nephrology community. Methods and Results: Using a Delphi-based approach, a multidisciplinary panel of 50 international experts from 26 countries reached a consensus on some of the open research questions regarding the link between MAFLD and CKD. Conclusions: This Delphi-based consensus statement provided guidance on the epidemiology, mechanisms, management and treatment of MAFLD and CKD, as well as the relationship between the severity of MAFLD and risk of CKD, which establish a framework for the early prevention and management of these two common and interconnected diseases.
出版者	AME PUBLISHING COMPANY
ISSN	2304-3881
EISSN	2304-389X
卷号	12 期号:3 页码:386-+
DOI	10.21037/hbsn-22-421
页数	21
WOS类目	Gastroenterology & Hepatology ; Nutrition & Dietetics ; Surgery
WOS研究方向	Gastroenterology & Hepatology ; Nutrition & Dietetics ; Surgery
WOS记录号	WOS:000989425000001
收录类别	SCIE ; PUBMED
在线发表日期	2023-02
URL	查看原文
PubMed ID	37351121
ESI高被引论文	2025-01
通讯作者地址	[Zheng, Ming-Hua]Wenzhou Med Univ, MAFLD Res Ctr, Dept Hepatol, Affiliated Hosp 1, 2 Fuxue Lane, Wenzhou 325000, Peoples R China. ; [George, Jacob]Univ Sydney, Storr Liver Ctr, Westmead Inst Med Res, Westmead Hosp, Sydney, NSW 2145, Australia.
引用统计
文献类型	期刊论文
条目标识符	https://kms.wmu.edu.cn/handle/3ETUA0LF/181017
专题	附属第一医院
通讯作者	George, Jacob; Zheng, Ming-Hua
作者单位	1.Jiangnan Univ, Dept Nephrol, Med Ctr, Wuxi, Jiangsu, Peoples R China; 2.Nantong Univ, Affiliated Wuxi Clin Coll, Wuxi, Jiangsu, Peoples R China; 3.Azienda Osped Univ Integrata Verona, Sect Endocrinol Diabet & Metab, Dept Med, Verona, Italy; 4.Univ Hosp Southampton, Southampton Natl Inst Hlth, Southampton, England; 5.Univ Hosp Southampton, Care Res Biomed Res Ctr, Southampton, England; 6.Univ Southampton, Southampton Gen Hosp, Southampton, England; 7.UCL, Dept Renal Med, London, England; 8.Chinese Univ Hong Kong, Dept Med & Therapeut, Hong Kong, Peoples R China; 9.Shanghai Jiao Tong Univ, Xin Hua Hosp, Dept Gastroenterol, Ctr Fatty Liver,Sch Med, Shanghai, Peoples R China; 10.Med Univ Innsbruck, Dept Internal Med Gastroenterol Endocrinol & Meta, Innsbruck, Austria; 11.Shanghai Jiao Tong Univ, Shanghai Gen Hosp, Dept Nephrol, Sch Med, Shanghai, Peoples R China; 12.Wurzburg Univ Clin, Dept Med, Div Nephrol, Wurzburg, Germany; 13.Fudan Univ, Zhongshan Hosp, Dept Endocrinol & Metab, Shanghai, Peoples R China; 14.Boston Univ, Boston Med Ctr, Sect Gastroenterol, Sch Med, Boston, MA USA; 15.Koc Univ, Div Nephrol, Dept Med, Sch Med, Istanbul, Turkiye; 16.Stanford Univ, Div Gastroenterol & Hepatol, Dept Med, Med Ctr, Palo Alto, CA USA; 17.Stanford Univ, Dept Epidemiol & Populat Hlth, Med Ctr, Palo Alto, CA USA; 18.Baylor Coll Med, Sect Nephrol, Houston, TX USA; 19.Baylor Coll Med, Inst Clin & Translat Res, Houston, TX USA; 20.Michael E DeBakey VA Med Ctr, Houston, TX USA; 21.Marmara Univ, Sch Med, Dept Gastroenterol, Istanbul, Turkiye; 22.Recep Tayyip Erdogan Univ, Sch Med, Dept Gastroenterol, Rize, Turkiye; 23.Southern Med Univ, Shunde Hosp, Dept Cardiol, Foshan, Peoples R China; 24.Univ Indonesia, Dr Cipto Mangunkusumo Natl Gen Hosp, Dept Internal Med, Div Hepatobiliary,Med Fac, Jakarta, Indonesia; 25.Univ Campania Luigi Vanvitelli, Dept Woman Child & Gen & Specialized Surg, Naples, Italy; 26.Univ Angers, HIFIH Lab, UPRES EA3859, Angers, France; 27.Angers Univ Hosp, Hepato Gastroenterol & Digest Oncol Dept, Angers, France; 28.Southern Med Univ, Nanfang Hosp, Dept Endocrinol & Metab, Guangzhou, Peoples R China; 29.Yonsei Univ, Dept Internal Med, Coll Med, Seoul, South Korea; 30.Third Mil Med Univ, Southwest Hosp, Dept Gastroenterol, Cholestat Liver Dis Ctr,Army Med Univ, Chongqing, Peoples R China; 31.Univ Milan, Fdn IRCCS Ca Granda Osped Policlin Mila, Dept Pathophysiol & Transplantat, Milan, Italy; 32.Natl & Kapodistrian Univ Athens, Dept Gastroenterol, Laiko Gen Hosp, Med Sch, Athens, Greece; 33.HUMANITAS Gradenigo Hosp, Emergency & Intens Care Med, Turin, Italy; 34.Univ Turin, Lab Diabetol & Metab, Dept Med Sci, Turin, Italy; 35.Singhealth, Changi Gen Hosp, Dept Gastroenterol & Hepatol, Singapore, Singapore; 36.Duke NUS Med Sch, Singapore, Singapore; 37.Helwan Univ, Dept Endem Med, Fac Med, Cairo, Egypt; 38.Medica Clin & Fdn, Liver Res Unit, Mexico City, DF, Mexico; 39.Univ Abierta Interamericana, Clin & Mol Hepatol, Ctr Altos Estudios Ciencias Humanas Salud CAECIHS, Consejo Nacl Invest Cient Tecn CONICET, Buenos Aires, Argentina; 40.Univ Oxford, Oxford NIHR Biomed Res Ctr, Oxford, England; 41.Postgrad Inst Med Educ & Res, Dept Hepatol, Chandigarh, India; 42.Univ Amsterdam, Med Ctr, Dept Vasc Med, Amsterdam, Netherlands; 43.Normal Univ, Dept Hepatol, Hosp Hangzhou, Hangzhou, Peoples R China; 44.Univ Malaya, Department Med, Kuala Lumpur, Malaysia; 45.Minia Univ, Dept Gastroenterol Hepatol & Endem Med, Fac Med, Al Minya, Egypt; 46.Nanjing Med Univ, Affiliated Hosp 2, Ctr Kidney Dis, Nanjing, Peoples R China; 47.Chulalongkorn Univ, Fac Med, Bangkok, Thailand; 48.Univ Lisbon, Clin Univ Gastrenterol, Lab Nutr, Fac Med, Lisbon, Portugal; 49.Kyoto Prefectural Univ Med, Dept Endocrinol & Metab, Grad Sch Med Sci, Kyoto, Japan; 50.Univ Seville, UCM Digest Dis, Inst Biomed Seville, CSIC,HUVR,Univ Hosp Virgen del Rocio, Seville, Spain; 51.Bangabandhu Sheikh Mujib Med Univ, Dept Hepatol, Dhaka, Bangladesh; 52.Makerere Univ, Dept Med, Coll Hlth Sci, Kampala, Uganda; 53.Yokohama City Univ, Dept Gastroenterol & Hepatol, Grad Sch Med, Yokohama, Kanagawa, Japan; 54.Westmead Hosp, Westmead Inst Med Res, Storr Liver Ctr, Sydney, NSW, Australia; 55.Univ Sydney, Sydney, NSW, Australia; 56.Tsinghua Univ, Beijing Tsinghua Changgung Hosp, Hepatopancreatobiliary Ctr, Beijing, Peoples R China; 57.Wenzhou Med Univ, Affiliated Hosp 1, Dept Hepatol, MAFLD Res Ctr, Wenzhou, Peoples R China; 58.Dev Chron Liver Dis Zhejiang Prov, Key Lab Diag & Treatment, Wenzhou, Peoples R China
通讯作者单位	附属第一医院
推荐引用方式 GB/T 7714	Sun, Dan-Qin,Targher, Giovanni,Byrne, Christopher D.,et al. An international Delphi consensus statement on metabolic dysfunction-associated fatty liver disease and risk of chronic kidney disease[J]. HEPATOBILIARY SURGERY AND NUTRITION,2023,12(3):386-+.
APA	Sun, Dan-Qin., Targher, Giovanni., Byrne, Christopher D.., Wheeler, David C.., Wong, Vincent Wai-Sun., ... & Zheng, Ming-Hua. (2023). An international Delphi consensus statement on metabolic dysfunction-associated fatty liver disease and risk of chronic kidney disease. HEPATOBILIARY SURGERY AND NUTRITION, 12(3), 386-+.
MLA	Sun, Dan-Qin,et al."An international Delphi consensus statement on metabolic dysfunction-associated fatty liver disease and risk of chronic kidney disease".HEPATOBILIARY SURGERY AND NUTRITION 12.3(2023):386-+.